Ozturk Ramazan, Yenigun Ezgi Coskun, Dede Fatih, Koc Eyup, Turgut Didem, Piskinpasa Serhan Vahit, Ozkayar Nihal, Odabas Ali Riza
Ankara Numune Education and Research Hospital, Department of Nephrology, Ankara, Turkey.
Iran J Kidney Dis. 2015 Jan;9(1):31-8.
Crescentic glomerulonephritis (CGN) is a fatal disease, rapidly leading to end-stage renal disease. Diagnosis should be accurate and treatment should be started immediately. We investigated the factors associated with the renal prognosis in CGN patients.
Forty-one patients with CGN who were followed up at the Nephrology Clinic of Ankara Numune Education and Research Hospital were divided into 2 arms of the dialysis-dependent group after treatment and the group that was followed up without dialysis. Demographic and clinical features along with biopsy findings during time of diagnosis were evaluated for both groups.
The mean age was 41.3 ± 17.2 years old and 26 were men. Twenty patients developed end-stage renal disease, requiring long-term dialysis. The dialysis-dependent group had higher serum creatinine levels (8.2 ± 3.6 mg/dL versus 2.6 ± 2.5 mg/dL) and percentages of glomeruli with crescent (83.1 ± 19.1% versus 56.4 ± 11.9%), were more likely to have oligoruia-anuria (90.5% versus 9.5%) and be dialysis-dependent at admission (86.4% versus 13.6%), and had longer elapsed time until the beginning of treatment (18.9 ± 10.4 days versus 10.6 ± 3.0 days) after treatment. At admission, their serum creatinine was greater than 4.2 mg/dL and the rate of crescentic glomeruli was greater than 63%.
In patients with CGN, renal prognosis is poor and the time of admission to the hospital, degree of renal insufficiency, presence of oligo-anuria, dialysis requirement, and the percentage of crescentic glomeruli on biopsy are closely related to progression to end-stage renal disease.
新月体性肾小球肾炎(CGN)是一种致命疾病,会迅速导致终末期肾病。诊断应准确无误且治疗应立即开始。我们对CGN患者肾脏预后的相关因素进行了研究。
在安卡拉努姆内教育与研究医院肾脏病门诊接受随访的41例CGN患者,治疗后分为依赖透析组和非透析随访组。对两组的人口统计学和临床特征以及诊断时的活检结果进行了评估。
平均年龄为41.3±17.2岁,男性26例。20例患者发展为终末期肾病,需要长期透析。依赖透析组的血清肌酐水平更高(8.2±3.6mg/dL对2.6±2.5mg/dL),新月体肾小球的比例更高(83.1±19.1%对56.4±11.9%),更易出现少尿-无尿(90.5%对9.5%)且入院时依赖透析(86.4%对13.6%),治疗后至开始治疗的时间更长(18.9±10.4天对10.6±3.0天)。入院时,他们的血清肌酐大于4.2mg/dL,新月体肾小球的比例大于63%。
在CGN患者中,肾脏预后较差,入院时间、肾功能不全程度、少尿-无尿的存在、透析需求以及活检时新月体肾小球的比例与进展至终末期肾病密切相关。